Search results
Raya’s pipeline ALS drug shows early signs of efficacy in Phase II trial
Clinical Trials Arena via Yahoo Finance· 2 days agoRaya Therapeutics said that it will initiate more amyotrophic lateral sclerosis (ALS) trials in 2025...
Diageo’s Guinness Nigeria sale puts new spotlight on struggling economy
Semafor via Yahoo Finance· 6 days agoThe roll call so far has featured British multinationals Unilever, and GSK; Ohio-based consumer...
Diana Taurasi says she'll 'always' wear '90s-style shorts
The Arizona Republic· 2 days agoDiana Taurasi is about to start showing some skin, but that doesn’t mean she’s about to start...
New JAK 1 Inhibitor Proves Promising in Phase 3 RA Trial
Medscape· 18 hours agoThe highly selective oral Janus kinase (JAK) inhibitor SHR0302 (ivarmacitinib) enables more patients...
AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis
Zacks· 18 hours agoFree Report) announced that the FDA has granted approval to its blockbuster drug, Skyrizi to treat adults with moderately to severely active ulcerative colitis (UC) in the United States. Skyrizi ...
Innovent Delivers Oral Presentation on Clinical Data of IBI363 (First-in-class PD-1/IL-2α-bias...
WTNH-TV New Haven· 6 days agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that...
AbbVie (ABBV) Buys Global Rights to Novel IBD Candidate
Zacks· 6 days agoAbbVie (ABBV) signs an exclusive global licensing deal with the Chinese company FutureGen to develop FG-M701, a next-generation TL1A antibody, for IBD indications.
Paris Olympics 2024: Diana Taurasi grateful to represent Team USA for a sixth time as retirement...
CBS Sports· 2 days agoIf you know women's basketball, then you know Diana Taurasi. What you likely didn't know is the...
Moderna Just Gave Investors Another Reason to Buy the Stock
The Motley Fool via AOL· 3 days agoThe biotech has other key late-stage pipeline candidates. Moderna is developing a vaccine for the...
Exxon adds some Dem lobbying muscle
Politico· 6 days agoThe cap eventually became law in Medicare, as one of Biden’s signature legislative achievements, adding more protections for the more than three million seniors who use insulin.” — “Some < ...